Erle Kristensen
- Chief Consultant; MD
- +47 230 71 002
Education
- 2022–to date: PhD candidate, University of Bergen, Norway
- 2000–2006: MD, University of Bergen, Norway
Affiliation
- Metabolomics & Metabolic Molecular Biology Group, Department of Medical Biochemistry, Oslo University Hospital - Rikshospitalet, Norway
- Mitochondrial Medicine & Neurogenetics group, University of Bergen, Norway
Research Summary
Dr. Kristensen is currently a PhD candidate studying POLG disease. Using data from a large Norwegian and European cohort of POLG patients, the main objectives are to describe the natural history and epidemiology of POLG disease, and to investigate possible relationships between genotype and phenotypic expression. She also takes a particular interest in pyridoxine (vitamin B6) and pyridoxine responsive epilepsy, and is a member of the international PDE Consortium (PDE Consortium).
Work Experience
- September 2020–to date, and January 2019–December 2019: Senior consultant, Norwegian National Unit for Screening and Diagnostics of Congenital Pediatric Metabolic Disorders, Oslo University Hospital, Norway
- January 2020–September 2020, and January 2017–December 2018: Senior consultant Norwegian National Unit for Newborn Screening, Oslo University Hospital, Norway
- June 2015–December 2016: Fellow in pediatrics, Department of pediatrics and adolescent medicine, Akershus University Hospital, Norway
- February 2009–June 2015: Fellow in pediatrics, Department of pediatrics, Hospital of Bodø, Norway
Links
NB: Check out our NEWS PAGE for the latest!